Product approvals

File- This Dec. 4, 2017, photo shows the Pfizer company logo at the company's headquarters in New York. The federal government has agreed to pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by the U.S. drugmaker and its German partner BioNTech. (AP Photo/Richard Drew, File)
July 22, 2020 - 5:40 pm
WASHINGTON (AP) — The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing, Health and Human Services Secretary Alex Azar announced Wednesday. The U.S. could buy another 500 million doses...
Read More
Orange Man, Brian McKee, delivers care packages to individuals who are isolating, to celebrate the 12th of July as traditional large-scale parades were cancelled this year due to the pandemic, in east Belfast, Monday, July 13, 2020. The Twelfth is being celebrated on 13 July as 12 July this year fell on a Sunday, to mark the anniversary of the victory of Protestant William of Orange over Catholic King James II at the Battle of the Boyne in July 1690. (Niall Carson/PA via AP)
July 13, 2020 - 1:28 pm
The outbreak of the coronavirus has dealt a shock to the global economy with unprecedented speed. Following are developments Monday related to the national and global response, the work place and the spread of the virus. ________________________ FRONT LINE VIRUS COMPANIES: — Two vaccine candidates...
Read More
Emiratis wearing face masks due to the coronavirus pandemic work on the floor of the Dubai Financial Market in Dubai, United Arab Emirates, Tuesday, July 7, 2020. Dubai reopened its Dubai Financial Market stock exchange Tuesday after closing its floor due to the coronavirus pandemic. (AP Photo/Jon Gambrell)
July 07, 2020 - 12:07 pm
The outbreak of the coronavirus has dealt a shock to the global economy with unprecedented speed. Following are developments Tuesday related to the national and global response, the work place and the spread of the virus. ________________________ FOOD & SHOPPING: — Overall retail sales are...
Read More
FILE - In this May 14, 2020, file pool photo Rick Bright, former director of the Biomedical Advanced Research and Development Authority, testifies before a House Energy and Commerce Subcommittee on Health hearing to discuss protecting scientific integrity in response to the coronavirus outbreak on Capitol Hill in Washington. Bright, a government whistleblower ousted from a leading role in battling COVID-19, alleged Thursday, June 25, that the Trump administration has intensified its campaign to punish him for revealing shortcomings in the U.S. response. (Shawn Thew/Pool via AP, File)
June 25, 2020 - 5:41 pm
WASHINGTON (AP) — A government whistleblower ousted from a leading role in battling COVID-19 alleged Thursday that the Trump administration has intensified its campaign to punish him for revealing shortcomings in the U.S. response. Dr. Rick Bright, former director of the Biomedical Advanced...
Read More
FILE - In this Aug. 2, 2018, file photo, the U.S. Food and Drug Administration (FDA) building is visible behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday, June 15, 2020, the game built by Boston-based Akili Interactive Labs can improve attention function. (AP Photo/Jacquelyn Martin, File)
June 15, 2020 - 7:17 pm
BOSTON (AP) — The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday the game built by Boston-based Akili Interactive Labs can improve attention function. The game, called EndeavorRx,...
Read More
In this April 3, 2020, photo, blue preservation solution is shown at Spectrum DNA in Draper, Utah. The company has developed a test kit to detect the coronavirus in patients' saliva. At least two Utah companies have developed tests and gotten emergency authorization from the U.S. Food and Drug Administration: molecular diagnostics company Co-Diagnostics and ancestry-testing kit maker Spectrum DNA. (AP Photo/Rick Bowmer)
April 13, 2020 - 4:52 pm
WASHINGTON (AP) — Rutgers University researchers have received U.S. government clearance for the first saliva test to help diagnose COVID-19, a new approach that could help expand testing options and reduce risks of infection for health care workers. The Food and Drug Administration authorized the...
Read More
This undated photo provided by Esperion Inc. shows the cholesterol-lowering drug Nexletol made by Esperion Therapeutics Inc. The Food and Drug Administration on Friday, Feb. 21, 2020 approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and others who have heart disease and need to further lower their bad cholesterol.(Esperion Inc. via AP)
February 21, 2020 - 4:15 pm
TRENTON, N.J. (AP) — U.S. regulatorson Friday approveda new type of cholesterol-lowering drug aimed at millions of people who can't tolerate — or don't get enough help from — widely used statin pills like Lipitor and Crestor. The Food and Drug Administration approved Esperion Therapeutics Inc.’s...
Read More
In this Nov. 5, 2019 photo, in St. Francis, Wis., Amy Carter looks at her Yorkshire terrier-Chihuahua mix Bentley, who has epilepsy. Carter, gives him CBD, which she says has reduced his seizures. The federal government has yet to establish standards for CBD that will help pet owners know whether it works and how much to give. But the lack of regulation has not stopped some from buying it, fueling a $400 million CBD market for pets that grew more than tenfold since last year and is expected to reach $1.7 billion by 2023, according to the cannabis research firm Brightfield Group. (AP Photo/Carrie Antlfinger)
January 07, 2020 - 9:43 am
Companies have unleash ed hundreds of CBD pet health products accompanied by glowing customer testimonials claiming the cannabis derivative produced calmer, quieter and pain-free dogs and cats. But some of these products are all bark and no bite. “You'd be astounded by the analysis we've seen of...
Read More
This undated photo provided by Amarin in November 2018 shows a capsule of the purified, prescription fish oil Vascepa. On Friday, Dec. 13, 2019, U.S. regulators approved expanded use of the medication for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. (Amarin via AP)
December 13, 2019 - 5:53 pm
TRENTON, N.J. (AP) — U.S. regulators on Friday approved expanded use of a fish oil-based drug for preventing serious heart complications in high-risk patients already taking cholesterol-lowering pills. Vascepa was approved years ago for people with sky-high triglycerides, a type of fat in blood...
Read More
This image provided by Sarepta Therapeutics in December 2019 shows a box and vial of their drug Vyondys 53. On Thursday, Dec. 12, 2019, U.S. health regulators said they approved this second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months earlier. (Sarepta Therapeutics via AP)
December 13, 2019 - 2:28 pm
WASHINGTON (AP) — U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago. The ruling marks the second time the Food and Drug Administration has granted preliminary...
Read More

Pages